Molbio Diagnostics IPO Oversubscribed 70x, Allotment Today
By ThePip Desk
Molbio Diagnostics’ Rs 939.70 crore IPO was massively oversubscribed 70.26 times. Allotment is finalized today, Aug 13, 2026, with listing on Aug 17.
Molbio Diagnostics’ initial public offering, raising Rs 939.70 crore, saw an overall subscription of 70.26 times. The allotment basis for the book-built issue is being finalized today, August 13, 2026.
Key IPO Figures
- Total IPO Size: Rs 939.70 crore
- Overall Subscription: 70.26 times
- Upper Price Band: Rs 807 per share
- Latest Grey Market Premium (GMP): Rs 154
- Estimated Listing Price: Rs 961
- Potential Listing Gain: 19.08%
The company’s shares are slated for listing on the NSE and BSE by August 17, 2026. Unsuccessful applicants can expect refunds by August 14, with shares credited to successful Demat accounts on the same day.
Check Allotment Status
Applicants can verify their allotment status via the official websites. These include BSE, NSE, and KFin Technologies, the registrar for the Molbio Diagnostics issue.
IPO Structure Breakdown
The IPO involved a fresh issue of 24.80 lakh shares, valued at Rs 200 crore. It also included an offer for sale (OFS) of 91.66 lakh shares, totaling Rs 739.70 crore.
Category-wise Subscription
- Qualified Institutional Buyers (QIB): 186.39 times
- Non-Institutional Investors (NII): 49.80 times
- Retail Investors: 12.96 times
- Employees: 13.28 times
The strong oversubscription indicates significant investor interest ahead of its anticipated market debut next week.